Mork Capital Management’s Celgene Corp CELG Stock Holding History

Mork Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-20,000	Closed	-$1.28M	–	118
2018 Q4	$1.28M	Sell	20,000 -5,600	-22%	-$413K	1.2%	21
2018 Q3	$2.29M	Hold	25,600	–	–	1.84%	4
2018 Q2	$2.03M	Buy	25,600 +10,600	+71%	+$880K	1.8%	2
2018 Q1	$1.34M	Hold	15,000	–	–	1.28%	24
2017 Q4	$1.56M	Buy	15,000 +5,200	+53%	+$587K	1.05%	18
2017 Q3	$1.43M	Hold	9,800	–	–	1.16%	18
2017 Q2	$1.27M	Hold	9,800	–	–	1.1%	19
2017 Q1	$1.22M	Hold	9,800	–	–	1.09%	20
2016 Q4	$1.13M	Hold	9,800	–	–	0.8%	31
2016 Q3	$1.02M	Hold	9,800	–	–	0.98%	31
2016 Q2	$967K	Hold	9,800	–	–	0.96%	33
2016 Q1	$981K	Hold	9,800	–	–	0.96%	28
2015 Q4	$1.17M	Hold	9,800	–	–	1.13%	11
2015 Q3	$1.06M	Hold	9,800	–	–	1.25%	16
2015 Q2	$1.13M	Hold	9,800	–	–	1.34%	9
2015 Q1	$1.13M	Hold	9,800	–	–	1.31%	10
2014 Q4	$1.1M	Buy	+9,800	New	+$1.03M	0.84%	17

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mork Capital Management's CELG Position: Q1 2019 in Review

Mork Capital Management sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 20,000 shares — an estimated $1.28M sold.

Mork Capital Management first reported a position in CELG in Q4 2014 and held it in 17 quarters. The position peaked at $2.29M in Q3 2018. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

Mork Capital Management reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
Mork Capital Management sold 20,000 Celgene Corp shares in Q1 2019, an estimated $1.28M.
Mork Capital Management first reported a position in Celgene Corp in Q4 2014 and held it in 17 quarters.
Mork Capital Management's Celgene Corp position peaked at $2.29M in Q3 2018.
1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Mork Capital Management's 13F filing for Q1 2019, filed 13 May 2019.